These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 32497811)

  • 1. Iron: Innocent bystander or vicious culprit in COVID-19 pathogenesis?
    Edeas M; Saleh J; Peyssonnaux C
    Int J Infect Dis; 2020 Aug; 97():303-305. PubMed ID: 32497811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria and microbiota dysfunction in COVID-19 pathogenesis.
    Saleh J; Peyssonnaux C; Singh KK; Edeas M
    Mitochondrion; 2020 Sep; 54():1-7. PubMed ID: 32574708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should we unstress SARS-CoV-2 infected cells?
    Csukasi F; Rico G; Becerra J; Duran I
    Cytokine Growth Factor Rev; 2020 Aug; 54():3-5. PubMed ID: 32563554
    [No Abstract]   [Full Text] [Related]  

  • 4. IL-6: Relevance for immunopathology of SARS-CoV-2.
    Gubernatorova EO; Gorshkova EA; Polinova AI; Drutskaya MS
    Cytokine Growth Factor Rev; 2020 Jun; 53():13-24. PubMed ID: 32475759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.
    Costela-Ruiz VJ; Illescas-Montes R; Puerta-Puerta JM; Ruiz C; Melguizo-Rodríguez L
    Cytokine Growth Factor Rev; 2020 Aug; 54():62-75. PubMed ID: 32513566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system.
    Coperchini F; Chiovato L; Croce L; Magri F; Rotondi M
    Cytokine Growth Factor Rev; 2020 Jun; 53():25-32. PubMed ID: 32446778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines.
    Fara A; Mitrev Z; Rosalia RA; Assas BM
    Open Biol; 2020 Sep; 10(9):200160. PubMed ID: 32961074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 infection may increase the risk of parkinsonism - Remember the Spanish flu?
    Eldeeb MA; Hussain FS; Siddiqi ZA
    Cytokine Growth Factor Rev; 2020 Aug; 54():6-7. PubMed ID: 32563553
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons.
    Nile SH; Nile A; Qiu J; Li L; Jia X; Kai G
    Cytokine Growth Factor Rev; 2020 Jun; 53():66-70. PubMed ID: 32418715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular underpinning of COVID-19.
    Wazny V; Siau A; Wu KX; Cheung C
    Open Biol; 2020 Aug; 10(8):200208. PubMed ID: 32847471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-Boosting, Antioxidant and Anti-inflammatory Food Supplements Targeting Pathogenesis of COVID-19.
    Mrityunjaya M; Pavithra V; Neelam R; Janhavi P; Halami PM; Ravindra PV
    Front Immunol; 2020; 11():570122. PubMed ID: 33117359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks.
    Blaess M; Kaiser L; Sauer M; Csuk R; Deigner HP
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?
    Liu B; Li M; Zhou Z; Guan X; Xiang Y
    J Autoimmun; 2020 Jul; 111():102452. PubMed ID: 32291137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?
    Costiniuk CT; Jenabian MA
    Cytokine Growth Factor Rev; 2020 Jun; 53():63-65. PubMed ID: 32467020
    [No Abstract]   [Full Text] [Related]  

  • 16. An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies.
    Dhama K; Patel SK; Pathak M; Yatoo MI; Tiwari R; Malik YS; Singh R; Sah R; Rabaan AA; Bonilla-Aldana DK; Rodriguez-Morales AJ
    Travel Med Infect Dis; 2020; 37():101755. PubMed ID: 32479816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the
    López-Iranzo FJ; López-Rodas AM; Franco L; López-Rodas G
    Curr Pharm Des; 2020; 26(35):4515-4521. PubMed ID: 32787748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathology of galectin-3: an increasingly promising target in COVID-19.
    Caniglia JL; Asuthkar S; Tsung AJ; Guda MR; Velpula KK
    F1000Res; 2020; 9():1078. PubMed ID: 33082935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and Management of Mechanical Circulatory Support During the COVID-19 Pandemic.
    Pham DT; Toeg H; De Paulis R; Atluri P
    Circulation; 2020 Jul; 142(1):10-13. PubMed ID: 32364404
    [No Abstract]   [Full Text] [Related]  

  • 20. Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies.
    Fagone P; Ciurleo R; Lombardo SD; Iacobello C; Palermo CI; Shoenfeld Y; Bendtzen K; Bramanti P; Nicoletti F
    Autoimmun Rev; 2020 Jul; 19(7):102571. PubMed ID: 32376402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.